ARIAD to Present at the 35th Annual J.P. Morgan Healthcare Conference
January 03 2017 - 7:35AM
Business Wire
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA), a rare
cancer-focused innovative biotechnology company, today announced
that it will present at the 35th Annual J.P. Morgan Healthcare
Conference. Paris Panayiotopoulos, president and chief executive
officer, will provide an overview of the Company’s business on
Monday, January 9, 2017 at 4:30 p.m. (PT).
The ARIAD presentation will be webcast live and can be accessed
by visiting the investor relations section of the Company’s website
at http://www.ariad.com/investor. A replay of the presentation will
also be available and archived on the site for three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts, is focused on discovering, developing and
commercializing precision therapies for patients with rare cancers.
ARIAD is working on new medicines to advance the treatment of rare
forms of chronic and acute leukemia, lung cancer and other rare
cancers. ARIAD utilizes computational and structural approaches to
design small-molecule drugs that overcome resistance to existing
cancer medicines. For additional information, visit
http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170103005023/en/
ARIAD Pharmaceuticals, Inc.For InvestorsManmeet Soni,
617-503-7298manmeet.soni@ariad.comorFor MediaLiza Heapes,
617-621-2315liza.heapes@ariad.com
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Sep 2023 to Sep 2024